Preliminary Results of Daratumumab, Cyclophosphamide, Thalidomide and Dexamethasone: A Quadruplet Intensified Treatment for Newly Diagnosed Multiple Myeloma (NDMM) Transplant Eligible (TE) Patients

Background: The inclusion of the CD38-targeting antibody daratumumab (Dara) increases the depth and duration of the response, as demonstrated by Dara-VTd and Dara-VRd protocols to treat NDMM - TE patients (pts). However, the access to new drugs is a challenge for some countries in Latin America. The...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Blood 2020-11, Vol.136 (Supplement 1), p.17-18
Hauptverfasser:	De Queiroz Crusoe, Edvan, Salvino, Marco Aurelio, Silva, Sarah Queiroz, Santos, Herbert Henrique de Melo, Santos, Allan de souza, Almeida, Alessandro de M., Vieira, Lucas de Oliveira, Fonseca, Cleverson Alves, Lucas, Larissa Ferreira, Leal, Joanna, Santos, Mariane Melo, Santos, Juliana Andrade, Adorno, Elisangela, Hungria, Vania T.M., Arruda, Maria da Gloria B.
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!